Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Genetic Disorders
Invitae sells reproductive health assets to Natera
By
LabPulse.com staff writers
Invitae on Monday has completed the sale of some of its reproductive health assets, including carrier screening and noninvasive prenatal screening, to Natera.
January 22, 2024
First FDA-approved CRISPR-based gene therapy cleared for 2nd indication
By
LabPulse.com staff writers
A month after the U.S. Food and Drug Administration (FDA) approved Vertex Pharmaceuticals’ and CRISPR Therapeutics’ Casgevy for the treatment of sickle cell disease, the agency has given it a second U.S. regulatory approval ahead of schedule.
January 17, 2024
Health Canada approves Pfizer’s hemophilia gene therapy
By
LabPulse.com staff writers
Health Canada, Canada’s regulatory agency, has approved Pfizer's Beqvez (fidanacogene elaparvovec) as a gene therapy treatment for adults with moderately severe to severe hemophilia B.
January 3, 2024
Sanford to launch rural precision medicine program in Upper Midwest
By
LabPulse.com staff writers
Sanford Health has announced a new genomics-based rural population health program in partnership with Helix.
December 15, 2023
U.K. trial approved for Hunter syndrome gene therapy
By
Matt Limb
U.K. regulators have approved the “first ever” trial of a revolutionary gene therapy for young children diagnosed with Hunter syndrome, a rare lysosomal storage disorder.
November 9, 2023
Genomics England, Oxford Nanopore to collaborate on sequencing rare diseases
By
Matt Limb
Genomics England and Oxford Nanopore Technologies have announced a strategic research partnership to resolve undiagnosed rare disease cases.
November 7, 2023
Oxford Nanopore partners with Fabric Genomics on assessment of genetic disease in children
By
Nick Paul Taylor
Oxford Nanopore Technologies and Fabric Genomics have teamed up to provide a sequencing analysis platform for neonatal and pediatric intensive care units.
November 1, 2023
PacBio, GeneDx team up to test if long-read sequencing improves pediatric diagnoses
By
Nick Paul Taylor
In the study, GeneDx, a genetic testing company, will use PacBio’s Revio sequencing system to perform WGS and analysis of samples from 350 people and their biological parents.
August 10, 2023
Whole genome sequencing finds genetic disorders missed by targeted test in babies
By
Nick Paul Taylor
WGS found a genetic disorder in 49% of the patients, compared to a 27% detection rate for NewbornDx. Overall, a molecular diagnostic variant was found in 51% of participants; 134 of the 297 identified variants were novel.
July 14, 2023
Genomics AI firm Genomenon acquires Boston Genetics
By
LabPulse.com staff writers
An expanded genomic interpretation team enabled by the acquisition supports its offerings for clinical diagnostic and pharmaceutical drug development programs, Genomenon said.
June 27, 2023
Genetic counseling may boost colorectal cancer patient empowerment: Study
By
Elissa Wolfson
A randomized controlled genetic counseling trial for those affected by colorectal cancer showed significant improvements in patient empowerment.
June 12, 2023
Polygenic risk scores may improve colorectal cancer screening
By
Elissa Wolfson
Polygenic risk scores may identify individuals at high risk of developing colorectal cancer, improving current screening strategies for the disease.
June 12, 2023
Page 1 of 3
Next Page